Company News: Page (1) of 1 - 10/18/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Merck to Present New Data on MS Portfolio: Rebif, Mavenclad, and Evobrutinib at ECTRIMS 2017

- Important safety and immune cell analyses further characterize the selective immune reconstitution approach of Mavenclad- Continued innovation with Rebif includes analysis of NEDA and use of MAGNIMS... (October 18, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Family,Adults,Family,Computers/Home Office,Communications,Digital Toys,Tablets,Networks,Smart Phone,tablet,Tablet,Sales,Marketing,Shipping & Receiving,Sales & Marketing,Database,Internet,Business Issues,Other,Administration,Management,Sales,Sales,Pro AV,Management,
Related Sites: Media Workstation ,   DMN Newswire ,   CEN - Consumer Electronics Net ,   CEN - Toys ,   CEN - HomeOffice ,   CEN - Notebooks ,   CEN - Peripherals ,   CEN - Phones ,   CEN - TVs ,   IBN - Business ,   IBN - Internet ,   VideoBasedTutorials ,   HTN - Health Technology Net ,   CEN - Tablets
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   CEN - Gadgets Newsletter ,   Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved